ESR1 and neoplasm: In particular, methylation of both the TAp73 promoter (P1) and the deltaNp73 promoter (P2) was higher in tumors compared to normal tissues, in ER-positive compared to ER-negative tumors (Figure 7A), and in luminal A and B compared to basal tumor subtype (Figure 7B).